1. Home
  2. AGMH vs SHPH Comparison

AGMH vs SHPH Comparison

Compare AGMH & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AGM Group Holdings Inc.

AGMH

AGM Group Holdings Inc.

HOLD

Current Price

$1.34

Market Cap

4.2M

Sector

Technology

ML Signal

HOLD

Logo Shuttle Pharmaceuticals Holdings Inc.

SHPH

Shuttle Pharmaceuticals Holdings Inc.

HOLD

Current Price

$1.02

Market Cap

4.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGMH
SHPH
Founded
2015
2012
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
4.2M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
AGMH
SHPH
Price
$1.34
$1.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
40.9K
110.5K
Earning Date
01-01-0001
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$0.12
52 Week High
$18.10
$5.59

Technical Indicators

Market Signals
Indicator
AGMH
SHPH
Relative Strength Index (RSI) 34.48 34.89
Support Level $1.30 $0.14
Resistance Level $2.46 $2.00
Average True Range (ATR) 0.10 0.12
MACD 0.02 -0.01
Stochastic Oscillator 19.07 3.68

Price Performance

Historical Comparison
AGMH
SHPH

About AGMH AGM Group Holdings Inc.

AGM Group Holdings Inc is an integrated technology company. The company focuses on blockchain-oriented ASIC chip design, high-end crypto miner production, and fintech technology software services. The company generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

Share on Social Networks: